1It is now widely accepted that there are two classes of sigma (a) binding sites, denoted and°2, and recently 3 subtype has been proposed. Selective c, and c2 receptor agonists are known to modulate the neuronal response to N-methyl-D-aspartate (NMDA) Conversely, N,N-dipropyl-2-[4-methoxy-3-(2-phenylethoxy)phenyl]-ethylamine monohydrochloride (NE-100) blocked the effects of (+)-pentazocine as well as those of BD-737, but not those of DTG. 5 The present results provide in vitro functional evidence for a a receptor type preferentially sensitive to BD-737, reduced haloperidol, BD-1008 and also to NE-100, that differs from the already identified ci, ci2 and ci3 sites.